As Biopharma Giants Reshape the Field, Cognition Therapeutics Sees a Place for Its Alzheimer’s Drug
GEN,
Lisa Ricciardi, Cognition Therapeutics president and CEO By Alex Philippidis With Eisai and Biogen winning full FDA approval in…
Lisa Ricciardi, Cognition Therapeutics president and CEO By Alex Philippidis With Eisai and Biogen winning full FDA approval in…
PURCHASE, N.Y., May 23, 2023 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (Nasdaq: CGTX), (the “Company” or “Cognition”…
(GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (Nasdaq: CGTX), (the “Company” or “Cognition”) has released its fifth “Conversa…
(GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (Nasdaq: CGTX), (the “Company” or “Cognition”) has released its fifth “Conversa…